Toolkit supporting provision of complex PrEP in England

05 November 2025

NICE has issued its full technology appraisal guidance for cabotegravir (Apretude) for preventing HIV-1 in adults and young people.

It is being recommended for those who are not able to have oral PrEP and if procured at the Medicines and Procurement Supply Chain framework price.

BASHH has published a toolkit to support clinics in England to identify the best options for supporting access to complex PrEP within their local systems in England. 

Download the toolkit here

BASHH members have access to our dedicated PrEP page for these and other resources. 

Members can also join BASHH Bitesize on Wedneday 5 November for a special session on provision of complex PrEP including cabotegravir (Apretude).